Ajanta Pharma Ltd
NSE:AJANTPHARM
Ajanta Pharma Ltd
NSE:AJANTPHARM
Price:
2 603.6
INR
0.18%
Market Closed
Market Cap:
325.2B
INR
Balance Sheet
Balance Sheet Decomposition
Ajanta Pharma Ltd
Ajanta Pharma Ltd
| Current Assets | 27.9B |
| Cash & Short-Term Investments | 7.6B |
| Receivables | 10.4B |
| Other Current Assets | 9.9B |
| Non-Current Assets | 20B |
| Long-Term Investments | 340m |
| PP&E | 17.9B |
| Intangibles | 133.2m |
| Other Non-Current Assets | 1.7B |
Balance Sheet
Ajanta Pharma Ltd
Ajanta Pharma Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
417
|
414
|
658
|
906
|
952
|
2 024
|
1 775
|
2 064
|
3 298
|
1 308
|
|
| Cash |
325
|
414
|
658
|
906
|
952
|
2 024
|
1 775
|
2 064
|
3 298
|
1 295
|
|
| Cash Equivalents |
92
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
|
| Short-Term Investments |
1 009
|
769
|
1 816
|
1 842
|
693
|
693
|
2 069
|
1 264
|
5 103
|
3 301
|
|
| Total Receivables |
3 066
|
4 159
|
3 776
|
5 822
|
5 619
|
8 513
|
8 579
|
11 071
|
11 251
|
13 563
|
|
| Accounts Receivables |
2 588
|
3 724
|
3 232
|
4 920
|
4 595
|
7 753
|
7 384
|
10 198
|
10 594
|
12 534
|
|
| Other Receivables |
478
|
435
|
544
|
902
|
1 024
|
760
|
1 195
|
873
|
657
|
1 029
|
|
| Inventory |
1 667
|
2 073
|
2 179
|
3 631
|
4 357
|
4 957
|
7 665
|
7 911
|
8 425
|
8 666
|
|
| Other Current Assets |
54
|
218
|
78
|
36
|
192
|
232
|
188
|
336
|
175
|
397
|
|
| Total Current Assets |
6 212
|
7 633
|
8 506
|
12 236
|
11 812
|
16 417
|
20 276
|
22 645
|
28 252
|
27 221
|
|
| PP&E Net |
4 540
|
6 854
|
9 212
|
11 065
|
14 332
|
15 829
|
16 296
|
16 474
|
16 982
|
17 210
|
|
| PP&E Gross |
4 540
|
6 854
|
9 212
|
11 065
|
14 332
|
15 829
|
16 296
|
16 474
|
16 982
|
17 210
|
|
| Accumulated Depreciation |
2 383
|
2 467
|
2 856
|
3 414
|
4 056
|
4 889
|
5 818
|
6 834
|
7 623
|
8 810
|
|
| Intangible Assets |
32
|
51
|
72
|
75
|
67
|
117
|
108
|
90
|
78
|
147
|
|
| Note Receivable |
48
|
60
|
429
|
769
|
278
|
264
|
421
|
398
|
63
|
95
|
|
| Long-Term Investments |
454
|
0
|
0
|
76
|
130
|
217
|
89
|
335
|
251
|
186
|
|
| Other Long-Term Assets |
147
|
282
|
258
|
265
|
343
|
343
|
598
|
613
|
1 166
|
1 526
|
|
| Total Assets |
11 434
N/A
|
14 880
+30%
|
18 477
+24%
|
24 486
+33%
|
26 962
+10%
|
33 187
+23%
|
37 787
+14%
|
40 556
+7%
|
46 790
+15%
|
46 384
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 091
|
1 456
|
1 782
|
2 496
|
2 252
|
3 623
|
3 739
|
3 272
|
4 228
|
4 632
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
51
|
463
|
0
|
0
|
333
|
429
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
212
|
202
|
2
|
8
|
20
|
194
|
116
|
65
|
94
|
118
|
|
| Other Current Liabilities |
493
|
478
|
682
|
956
|
1 172
|
1 816
|
2 632
|
3 138
|
7 071
|
4 203
|
|
| Total Current Liabilities |
1 847
|
2 599
|
2 467
|
3 461
|
3 776
|
6 062
|
6 486
|
6 474
|
11 393
|
8 953
|
|
| Long-Term Debt |
333
|
149
|
10
|
10
|
7
|
127
|
198
|
186
|
262
|
235
|
|
| Deferred Income Tax |
138
|
193
|
273
|
470
|
589
|
812
|
922
|
1 019
|
977
|
1 085
|
|
| Other Liabilities |
73
|
31
|
50
|
132
|
138
|
198
|
225
|
234
|
278
|
438
|
|
| Total Liabilities |
2 390
N/A
|
2 971
+24%
|
2 800
-6%
|
4 072
+45%
|
4 510
+11%
|
7 198
+60%
|
7 831
+9%
|
7 912
+1%
|
12 910
+63%
|
10 710
-17%
|
|
| Equity | |||||||||||
| Common Stock |
177
|
177
|
177
|
177
|
175
|
175
|
174
|
172
|
253
|
253
|
|
| Retained Earnings |
8 106
|
10 916
|
14 691
|
19 365
|
22 229
|
25 706
|
29 750
|
32 521
|
33 528
|
35 258
|
|
| Additional Paid In Capital |
757
|
760
|
761
|
774
|
0
|
11
|
0
|
0
|
0
|
2
|
|
| Other Equity |
4
|
57
|
49
|
98
|
47
|
97
|
32
|
49
|
100
|
161
|
|
| Total Equity |
9 044
N/A
|
11 909
+32%
|
15 677
+32%
|
20 414
+30%
|
22 452
+10%
|
25 989
+16%
|
29 956
+15%
|
32 643
+9%
|
33 880
+4%
|
35 674
+5%
|
|
| Total Liabilities & Equity |
11 434
N/A
|
14 880
+30%
|
18 477
+24%
|
24 486
+33%
|
26 962
+10%
|
33 187
+23%
|
37 787
+14%
|
40 556
+7%
|
46 790
+15%
|
46 384
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
132
|
132
|
132
|
132
|
131
|
131
|
130
|
129
|
126
|
126
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
